Caio Carvalho Novais de Moraes

CV Lattes ORCID Google Scholar Citations

Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

graduation at Ciências Biológicas from Universidade Federal do Vale do São Francisco (2024). (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Ongoing (most recent)

Abstract
Cefiderocol is a promising antimicrobial approved by the Food and Drug Administration (FDA-USA) and the European Medicines Agency (EMA). It is a last-resort option for carbapenem-resistant (CR) Gram-negative bacteria, especially CR Enterobacterales, metallo-beta-lactamase-producing Pseudomonas aeruginosa and CR Acinetobacter baumannii. However, as it is a new therapeutic option, data on t…
Evaluation of cefiderocol activity against Gram-negative bacilli isolated from a university hospital in the city of São Paulo, BP.MS

Virtual Library in numbers * Updated data on August 09, 2025

Total / Available in English

1 / 1	Ongoing scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Ana Cristina Gales

Keywords used by the researcher

Biological Sciences Microbiology

Please report errors on the page using this form.

Short URL

Abstract